GlaxoSmithKline (GSK) Debt/EBITDA US GAAP (year values)

2022 2022 2022 2023 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 1.49 1.52 1.49 1.36 1.36   -0.41  
Changes by years, y/y, % -42% +2% -2% -8% 0%     -14.7%

GlaxoSmithKline. Debt/EBITDA

Created with Highcharts 6.0.6-0.7-0.7-0.9-0.9-1.0-1.0-1.0-1.0-0.8-0.8-0.8-0.8-0.7-0.7-0.9-0.9-1.0-1.02.22.21.01.00.50.50.40.40.40.40.50.50.10.10.30.30.30.30.20.20.30.30.30.30.30.30.70.71.21.20.90.91.61.60.90.91.61.61.51.52.82.80.80.83.23.22.42.42.42.43.03.03.03.02.52.52.72.72.42.42.62.62.32.32.62.61.51.51.51.51.51.51.41.41.41.4-0.4-0.4198619871988198919901991199219931994199519951996199719981999200020012002200320032004200520062007200820092010201120122013201420152016201720172018201820192019202020202021202120222022202220232023LTM-2-101234smart-lab.ru

GlaxoSmithKline. Debt/EBITDA, changes, %

Created with Highcharts 6.0.622.122.110.410.42.32.3-15.3-15.3-9.7-9.7-2.3-2.316.316.312.312.3-328.5-328.5-55.0-55.0-45.2-45.2-24.1-24.1-7.5-7.525.725.7-86.9-86.9446.1446.1-2.0-2.0-100.0-100.020.220.2-2.0-2.01.61.6149.1149.171.871.8-20.8-20.874.474.4-42.5-42.573.973.9-8.8-8.892.792.7-70.7-70.7289.1289.1-26.3-26.326.426.4-15.5-15.57.47.4-10.2-10.24.74.7-12.0-12.013.313.3-41.8-41.82.42.4-2.3-2.3-8.4-8.4-0.5-0.5-130.5-130.519871988198919901991199219931994199519951996199719981999200020012002200320032004200520062007200820092010201120122013201420152016201720172018201820192019202020202021202120222022202220232023LTM-400-2000200400600smart-lab.ru

GlaxoSmithKline (GSK) Debt/EBITDA US GAAP (quarter values)

2024Q2 2024Q1 2024Q3 2024Q2 2024Q3   LTM ?
Debt/EBITDA 1.44 1.41 -0.32 1.40 -0.40   -0.41
Changes by years, y/y, % -9% -14% -124% -11% -130%    
Changes by quarters, q/q, % +14% -2% -123% -535% -129%    

GlaxoSmithKline. Debt/EBITDA

Created with Highcharts 6.0.60.40.40.50.50.80.81.01.019.219.20.10.10.30.30.30.30.50.50.30.30.30.30.50.50.50.50.20.20.30.30.30.30.40.40.30.30.20.20.20.20.10.10.30.30.00.00.10.10.20.20.30.30.30.30.40.40.40.40.70.70.80.81.01.01.01.01.21.21.11.10.90.91.11.10.90.90.90.91.01.01.01.01.61.61.51.51.31.31.31.30.90.91.01.01.11.11.71.71.61.61.81.81.81.81.71.71.51.51.71.71.91.92.32.32.82.80.60.60.70.70.80.80.80.83.53.55.35.34.54.53.23.22.82.82.62.62.22.22.42.42.62.64.64.64.74.73.23.23.43.43.23.23.03.02.92.93.23.23.03.03.23.21.91.91.91.91.91.92.02.02.32.32.32.32.42.42.52.51.61.61.91.91.91.91.41.41.41.41.41.41.41.41.61.61.81.81.61.61.61.61.51.51.61.61.21.21.41.41.31.31.31.31.31.31.41.41.41.4-0.3-0.31.41.4-0.4-0.41996Q21998Q22000Q12001Q12002Q12003Q12003Q12004Q12004Q12005Q12005Q12006Q12006Q12007Q12007Q12008Q12008Q12009Q12009Q12010Q12010Q12011Q12011Q12012Q12012Q12013Q12013Q12014Q12014Q12015Q12015Q12016Q12016Q12017Q12017Q12018Q12018Q12019Q12019Q12020Q12020Q12020Q22021Q22021Q12021Q22022Q22022Q32022Q42023Q12023Q12023Q32023Q42024Q12023Q42024Q12024Q2-50510152025smart-lab.ru

GlaxoSmithKline. Debt/EBITDA, changes, y/y, %

Created with Highcharts 6.0.620.320.358.258.226.526.5-92.8-92.8-98.3-98.3393.4393.458.758.7-0.8-0.8-43.8-43.849.349.3-9.7-9.7-31.7-31.7-39.0-39.024.624.6-23.1-23.120.520.5-41.4-41.4-36.9-36.9-85.1-85.1-0.5-0.5-15.3-15.3-72.4-72.4349.5349.50.30.342.142.133.333.379.679.6150.8150.879.279.239.539.5136.8136.868.268.26.96.9-19.6-19.65.55.5-21.2-21.2-18.2-18.28.78.7-3.5-3.574.474.444.644.6-21.8-21.822.622.6-42.5-42.5-24.6-24.615.915.932.832.873.973.97.27.213.513.5-0.2-0.2-8.8-8.80.30.329.129.136.536.592.792.7-74.8-74.8-75.3-75.3-66.4-66.4-70.7-70.7347.8347.8534.3534.3487.2487.2289.1289.1-38.6-38.6-18.5-18.5-51.5-51.5-26.3-26.317.317.395.595.5113.3113.332.832.8-26.7-26.70.40.4-35.2-35.2-7.6-7.66.36.33.63.64.54.5-34.3-34.3-40.3-40.32.42.4-27.0-27.030.530.5-30.0-30.0-24.2-24.2-24.2-24.20.70.7-7.6-7.60.70.7-16.4-16.44.14.1-16.4-16.4-12.4-12.4-5.6-5.6-17.4-17.4-10.2-10.2-10.2-10.2-9.4-9.4-13.6-13.6-123.8-123.8-11.4-11.4-129.6-129.61997Q21999Q22001Q12002Q12003Q12003Q12004Q12004Q12005Q12005Q12006Q12006Q12007Q12007Q12008Q12008Q12009Q12009Q12010Q12010Q12011Q12011Q12012Q12012Q12013Q12013Q12014Q12014Q12015Q12015Q12016Q12016Q12017Q12017Q12018Q12018Q12019Q12019Q12020Q12020Q12021Q12021Q12022Q12022Q22023Q22023Q22023Q22023Q32023Q42024Q22024Q32024Q3-2000200400600smart-lab.ru

GlaxoSmithKline. Debt/EBITDA, changes, q/q, %

Created with Highcharts 6.0.620.320.358.258.226.526.51900.41900.4-99.6-99.6368.2368.25.45.450.650.6-34.1-34.1-14.7-14.775.075.0-8.2-8.2-50.1-50.122.322.31.91.923.723.7-21.8-21.8-25.0-25.0-15.8-15.8-69.8-69.8421.6421.6-83.8-83.869.969.9212.5212.516.316.322.222.29.29.215.815.862.462.410.310.326.526.54.54.515.415.4-7.4-7.4-13.1-13.113.713.7-13.9-13.9-5.0-5.014.414.43.13.155.655.6-7.0-7.0-15.8-15.80.70.7-27.0-27.03.33.312.212.256.956.9-4.4-4.412.112.11.21.2-8.1-8.1-12.5-12.514.714.712.612.621.021.023.423.4-79.6-79.621.321.310.110.17.57.5316.6316.652.252.2-13.9-13.9-28.8-28.8-13.8-13.8-5.4-5.4-16.4-16.48.18.18.58.580.280.20.90.9-32.7-32.78.98.9-7.8-7.8-4.2-4.2-3.9-3.910.610.6-6.3-6.34.94.9-39.5-39.5-1.3-1.33.73.717.917.92.62.65.45.4-35.3-35.317.117.1-24.1-24.1-2.2-2.215.815.87.57.5-6.9-6.9-2.7-2.7-5.5-5.55.85.8-22.2-22.210.310.3-1.0-1.0-6.1-6.113.713.7-2.0-2.0-123.0-123.0-534.6-534.6-128.7-128.71997Q21999Q22000Q22001Q22002Q22003Q22003Q22004Q22004Q22005Q22005Q22006Q22006Q22007Q22007Q22008Q22008Q22009Q22009Q22010Q22010Q22011Q22011Q22012Q22012Q22013Q22013Q22014Q22014Q22015Q22015Q22016Q22016Q22017Q22017Q22018Q22018Q22019Q22019Q22020Q22020Q42021Q12021Q32021Q42022Q12022Q22022Q32022Q42023Q22023Q22023Q22023Q32023Q42024Q22024Q32024Q3-1000-50005001000150020002500smart-lab.ru